ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,250.00
-50.00 (-0.94%)
Last updated: Aug 26, 2025
-0.94%
Market Cap379.14B
Revenue (ttm)654.54M
Net Income (ttm)-5.69B
Shares Out73.91M
EPS (ttm)-101.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume486,922
Average Volume697,434
Open5,200.00
Previous Close5,300.00
Day's Range5,180.00 - 5,370.00
52-Week Range4,455.00 - 8,300.00
Betan/a
RSI46.29
Earnings Daten/a

About ImmuneOncia Therapeutics

ImmuneOncia Therapeutics, Inc., an immuno-oncology-centric biopharmaceutical company, develops immuno-oncology drugs for the treatment of cancer. It develops IMC-001, a human monoclonal antibody of the IgG1 type that targets PD-L1 an immunotherapy for cancer, which is in Phase II clinical trial for the treatment of NK/T cell lymphoma and solid cancer patients with high tumor mutation burden; and IMC-002, a human monoclonal antibody of the IgG4 type targeting human CD47, which is in Phase I a clinical trial for the treatment of solid cancers, su... [Read more]

Industry Pharmaceutical Preparations
Founded 2016
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 424870
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.